The occlusion of a central venous catheter (CVC) commonly leads to it being removed from the patient. If central venous access is still required, then the patient will be re-exposed to the hazards of CVC insertion. On occasions where the original central venous access has been achieved with difficulty, or where clinical circumstances have altered (e.g. development of coagulopathy), one is loath to remove and replace a CVC unnecessarily. It is possible to avoid the hazards of reinsertion if the catheter occlusion can be cleared and obviate the removal of the CVC. Implicit in this practice is the assumption that clearing the occlusion is less hazardous than resiting the CVC.
The occlusion of a central venous catheter (CVC) commonly leads to it being removed from the patient. If central venous access is still required, then the patient will be re-exposed to the hazards of CVC insertion. On occasions where the original central venous access has been achieved with difficulty, or where clinical circumstances have altered (e.g. development of coagulopathy), one is loath to remove and replace a CVC unnecessarily. It is possible to avoid the hazards of reinsertion if the catheter occlusion can be cleared and obviate the removal of the CVC. Implicit in this practice is the assumption that clearing the occlusion is less hazardous than resiting the CVC.
Several strategies for clearing occluded silastic CVCs have been described. These include the use of urokinase [1] [2] [3] , hydrochloric acid (HCl) [4] [5] [6] and ethanol 6, 7 .
The relative merits of each method varies with the presumed cause of the occlusion 6 . Given that these practices are employed on occasion to clear occluded polyurethane CVCs, we have investigated the in vitro effects of HCl and ethanol on the structure of such catheters using electron microscopy.
METHOD
A method similar to that described by Shulman et al 8 
was used.
Six 20 cm single-lumen central venous catheters (Certofix®, Mono V 320, 16 gauge Certon® polyurethane catheter, B. Braun Melsungen AG ) were used in the evaluation. These catheters were the type in routine use at this institution at the time of the study. Two were used as controls (saline), two were treated with 0.1 normal hydrochloric acid (HCl), and two with 70% ethanol.
Initially a 1 cm length was cut from each catheter, and stored in individually sealed and labelled containers. Then two catheters were instilled with 0.1 normal HCl and another two were instilled with 70% 
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Anaesthesia and Intensive Care, Vol. 25, No. 4, August 1997 ethanol. The two control catheters were instilled with normal saline. In all cases the volume of instillate was 1.2 ml (i.e. three times the luminal volume of the CVC), and the catheters were locked off using the attached slide-clamp, thus leaving them filled with the particular solution.
Twenty-four hours later, the catheters were flushed with 1.6 ml of sterile water (i.e. four times the luminal volume). A further one-centimetre length was cut from each catheter and stored in individual sealed containers. Each container was code-labelled so that the electron-microscopist was blinded to the solution that had been instilled. The respective catheters were then refilled with HCl, ethanol or saline as before. The whole process was repeated daily until the 20 cm catheter lengths were completely sectioned. The catheters were inspected daily for any evidence of macroscopic damage.
Scanning electron microscopy was performed on all of the catheter sections. A 5 mm sample was cut from each 1 cm segment, and sectioned longitudinally. These were mounted on aluminium stubs with carbon tape and sputter-coated with goldpalladium (Au-Pd). They were then examined in a Hitachi FESEM 4100 scanning electron microscope at 5 kV. Catheter samples were evaluated at a number of different magnifications for evidence of abnormalities (e.g. pitting, erosion). Measurements of the catheter wall thicknesses were made to enable quantification of any significant erosion that may have been occurring. Findings in the treatment groups were compared to those in the control group.
Measurements of CVC wall thickness were compared using a paired Student's t test, and the Kruskall Wallis test. A P <0.05 was considered significant.
RESULTS
Throughout the study period, there was no apparent macroscopic damage to any of the CVCs. It was noted that the ethanol-treated catheters became appreciably softer than the other two groups. The study design did not include any provision to quantify this softening, and no attempt was made to do so.
Representative photomicrographs are shown in Figures 1 and 2 . The irregularity and heterogeneity of the internal surface prior to treatment can be seen in the pre-treatment pictures (day 0). Over the entire study period, there was no significant damage to the lumen surfaces as observed at lower magnifications (up to 600 times). Occasional imperfections or irregularities were seen, and these have been attributed to the manufacturing process or possible surface-debris artefact. However, as the study progressed there was loss of fine surface detail seen at higher magnifications (1000 times or higher) with the sporadic appearance of small pits ( Figure 3 ). There was no clear temporal or treatment-related pattern to this occurrence, but there was a tendency for it to occur more often in the HCl-treated CVC, and for it to occur later in the course of the treatment. It did however occur in the saline and ethanol groups as well.
The thickness of the catheter walls did not alter significantly during the course of the study. At the start of the study, the mean catheter wall thickness was measured at 252.4 µm (SEM 1.5 µm; range 249.2-257.8 µm), and the final catheter sections had a mean wall thickness of 250.4 µm (1.4; 245.6-255.0). This difference was not significant (P=0.15). The intergroup differences in the changes in catheter wall thickness during the study period were also not significant (P=0.10). There was no evidence to suggest CVC perforation.
DISCUSSION
Using electron microscopy, we have demonstrated that there is no appreciable structural damage caused to the lumen surface of polyurethane CVC after prolonged exposure to either 0.1 normal hydrochloric acid or 70% ethanol when compared to a saline control. The appearance at higher magnifications of small pits with apparent loss of fine surface detail in the later stages of the study are of questionable clinical relevance. There was no significant change in wall thickness nor any suggestion of impending CVC perforation. Surface detail changes tended to occur more frequently in the HCl group rather than the other two. These changes however occurred only after what amounts to a hugely exaggerated exposure, and do not represent a compromise of safety. It is difficult to envisage any circumstance in which a CVC would be reasonably exposed to more than two or three of these treatments. The manufacturing process presumably allows for some tolerance of varying wall thickness, and the differences we have observed could easily fall within this tolerance range.
Whilst the systemic effects of such small amounts of hydrochloric acid and ethanol have been reported as being minimal [4] [5] [6] [7] , the structural effects of these treatments on polyurethane catheters has not been previously assessed. There is no available evidence of any toxic breakdown products formed with polyurethane and either substance. Intuitively, it seems possible that corrosive substances such as HCl may potentially damage the catheter. Damage to silicone rubber CVC does not occur after prolonged exposure to HCl 8 . Manufacturers of polyurethane CVC have indicated that HCl is probably safe with polyurethane, but they were not able to supply specific information. However, there are some concerns with ethanol, as higher concentrations of alcohol might be expected to reduce the tensile strength of the catheters after exposures of 15 minutes or more (personal communication, Arrow International Inc., and B.Braun AG). The observed softening of CVC in the ethanol group is in keeping with this concern, and raises additional considerations regarding its use to clear occluded CVC. For fear of possible CVC rupture, gentle injection techniques are advised in clearing occluded CVC with these solutions 4, 6, 7, 9 . However, one must assume that forceful injection is occasionally employed, and it is possible that a softened CVC could rupture as a result. Catheter-softening was an unexpected finding, and the protocol did not include any testing of tensile strength. Without quantification of the softening occurring with ethanol, the safety of this technique cannot currently be endorsed for polyurethane CVC.
Polyurethane CVCs sometimes become blocked, and unnecessary removal and resiting of them is undesirable. Following experience with silicone catheters, the safety of urokinase for unblocking polyurethane CVCs has been assumed 9 without being documented. An algorithm produced for clearance of occluded CVCs 6 does not explicitly specify the type of CVC. The implications from the text suggest that it is for use with silastic CVCs. However, this lack of catheter specification may lead one to apply the algorithm to clearing an occluded polyurethane CVC. Other available descriptions 4,5,7 have described the use of these therapies only with silastic catheters. Clearing an occlusion ought to be at least as safe as removal and replacement of a CVC in any given situation. The choice of the clearing agent depends on the presumed cause of the occlusion. Thrombolytic agents are advised to clear thrombi, HCl for mineral and/or drug deposits and ethanol for lipid deposits associated with parenteral nutrition 6 . Of considerable concern, blockage is often associated with infection of the catheter. In this setting, HCl can be a dual purpose treatment for both clearing the line and treating the infection 10 , and it should be considered as a firstline treatment in preference to thrombolytics. We have used 0.1N HCl without prior use of thrombolytic agents to good effect in a small group of patients with occluded polyurethane CVC without any evident problems. We wished to confirm catheter safety with such practice prior to any consideration of formally evaluating the efficacy of the treatment. Previous observation of disfigurement of a polyurethane CVC that had been used for an ethanol infusion added to our interest in the particular effects of ethanol treatment, although to date, we have not used this treatment to treat any occluded CVC. The catheters in this study were softened by ethanol, but without evidence of significant damage to their microscopic structure.
This study has not revealed any clear evidence that the practice of treating occlusions of polyurethane CVCs with 0.1N hydrochloric acid will compromise the structural safety of the catheters. A qualitative softening of polyurethane CVCs has been observed with extended exposure to 70% ethanol, and limits the recommendations for its use in this setting. We suggest that attempting to clear an occluded polyurethane CVC with 0.1N HCl is a safe alternative to automatic replacement or resiting.
